The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PEC-PRO: A new prognostic score from a series of 93 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
 
Justine Gantzer
Travel, Accommodations, Expenses - Mundipharma; PharmaMar
 
Maud Toulmonde
Speakers' Bureau - Blueprint Medicines
Travel, Accommodations, Expenses - PharmaMar
 
François Severac
No Relationships to Disclose
 
Ali N. Chamseddine
No Relationships to Disclose
 
Céline Charon-Barra
No Relationships to Disclose
 
Agathe Bourgmayer
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Thomas Ryckewaert
No Relationships to Disclose
 
Thibaud Valentin
No Relationships to Disclose
 
Nelly Firmin
No Relationships to Disclose
 
Loic Chaigneau
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Philippe Follana
Travel, Accommodations, Expenses - AstraZeneca/Merck; GlaxoSmithKline; MSD; Novartis
 
Nathalie Rioux-Leclercq
No Relationships to Disclose
 
Laurence Bozec Lemoal
No Relationships to Disclose
 
Florence Duffaud
Consulting or Advisory Role - Bayer Health; Bayer Health; BluPrint Oncology; GlaxoSmithKline
Travel, Accommodations, Expenses - Leo Pharma; PharmaMar
 
Patrick Schöffski
Honoraria - Blueprint Medicines
Consulting or Advisory Role - Adcendo; Blueprint Medicines; Boehringer Ingelheim; Deciphera; Ellipses Pharma; Exelixis; Merck; PharmaMar; SQZ Biotechnology; Studiecentrum voor Kernenergie (SCK CEN); Transgene
Research Funding - CoBioRes NV (Inst); Eisai (Inst); G1 Therapeutics (Inst); Genmab (Inst); Merck (Inst); ONA therapeutics (Inst); PharmaMar (Inst); Sartar Therapeutics (Inst)
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Karyopharm Therapeutics; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Mehdi Brahmi
Honoraria - Amgen
Expert Testimony - Bayer
Travel, Accommodations, Expenses - mundipharma; PharmaMar
 
Gabriel G. Malouf
Consulting or Advisory Role - ipsen; MSD; Pfizer
Travel, Accommodations, Expenses - Ipsen